4892.T
Cyfuse Biomedical K.K.
グロース · 医薬品 · 医薬品 · JP
JPY 587.00
+4.45%Margins
Gross margin
49.5%
EBITDA margin
-344.6%
EBIT margin
-360.0%
Net margin
-331.7%
FCF margin
-252.7%
-27.7%
Return on equity
-17.9%
Return on assets
-21.3%
Return on invested capital
0.05x
Asset turnover
-JPY 534.0M
Cash from operations
JPY 247
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026